论文信息 - Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study - 字舞流文

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

M. Dogan | R. Uslu | A. Bilici | G. Basaran | D. Erdem | S. Paydaş | M. Uysal | S. Turhal | M. Kaplan | O. Tanrıverdi | H. Çınkır | D. Tural | N. Avcı | O. F. Olmez | M. Değirmenci | I. Beypinar | A. Demir | T. Şakalar | I. Bilgetekin | Sema Turker | S. Menekşe | A. Sakin | S. Temiz | O. Acikgoz | F. Yıldız | S. Sezgin Goksu | Semih Akin | Merve Turan | M. A. Kaplan | F. Yildiz | M. Doğan